Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $4.17B. Across the group, the median move over the past trading day is −1.61%. Price change over the past year runs from −30.7% to +39.6% across the middle 80 percent of the group, with a median of −11.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| 000100.KS | Yuhan Corporation | $4.50B | Mid cap | −27.54% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.